Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Azithromycin Capsule vs Sumamed in Healthy Chinese Subjects
NCT06149117Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Nov 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in upper respiratory tract infection (URI), lower respiratory tract infection (LRTI), skin infection (SSTI), cellulitis, Genital infection (STI), sponsored by Peking University People's Hospital. Started Nov 2022; status: completed.
02
Drugs
azithromycin
03
Conditions
upper respiratory tract infection (URI)lower respiratory tract infection (LRTI)skin infection (SSTI)cellulitisGenital infection (STI)
Beyond the preview
Go deeper on NCT06149117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06149117.